{"id":60,"date":"2005-12-22T08:54:01","date_gmt":"2005-12-22T00:54:01","guid":{"rendered":"http:\/\/www.chinacsr.com\/2005\/12\/22\/sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/"},"modified":"2005-12-22T08:54:01","modified_gmt":"2005-12-22T00:54:01","slug":"sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing","status":"publish","type":"post","link":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/","title":{"rendered":"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing"},"content":{"rendered":"

Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers at the Beijing Sino-Japan Friendship Hospital in Beijing.
\n
\nDue to this vaccine's mature technology, China's State Food and Drug Administration (SFDA) earlier approved modification to \"fast-track\" the clinical trial process from 3 phases to only 2 stages.<\/p>\n

Stage I includes 120 healthy volunteers, ages 18 – 60 years and is expected to take nine-months. However, preliminary results should be available by the end of March, 2006.<\/p>\n

Sinovac partnered with Beijing Sino-Japan Friendship Hospital for the successful Phase I SARS clinical trials in 2004. <\/p>\n

Protocols for clinical trials are strictly regulated and include compliance with SFDA's National Institute for the Control of Pharmaceutical and Biological Products (NICPBP), World Health Organization (WHO) \"Guidelines on Clinical Evaluation of Vaccines,\" and other relevant regulations.<\/p>\n

The trials will be compliant with Good Clinical Practices (GCP) procedures, including ethical guidelines.<\/p>\n","protected":false},"excerpt":{"rendered":"

Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers at the Beijing Sino-Japan Friendship Hospital in Beijing.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-60","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nSinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China<\/title>\n<meta name=\"description\" content=\"Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\" \/>\n<meta property=\"og:description\" content=\"Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/\" \/>\n<meta property=\"og:site_name\" content=\"ChinaCSR.com\" \/>\n<meta property=\"article:published_time\" content=\"2005-12-22T00:54:01+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif\" \/>\n<meta name=\"author\" content=\"CSR and Sustainability Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@China_CSR\" \/>\n<meta name=\"twitter:site\" content=\"@China_CSR\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"CSR and Sustainability Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/\"},\"author\":{\"name\":\"CSR and Sustainability Editor\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba\"},\"headline\":\"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing\",\"datePublished\":\"2005-12-22T00:54:01+00:00\",\"dateModified\":\"2005-12-22T00:54:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/\"},\"wordCount\":161,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/\",\"url\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/\",\"name\":\"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\",\"isPartOf\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif\",\"datePublished\":\"2005-12-22T00:54:01+00:00\",\"dateModified\":\"2005-12-22T00:54:01+00:00\",\"description\":\"Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers\",\"breadcrumb\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage\",\"url\":\"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif\",\"contentUrl\":\"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.chinacsr.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#website\",\"url\":\"https:\/\/www.chinacsr.com\/en\/\",\"name\":\"ChinaCSR.com\",\"description\":\"Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\",\"publisher\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.chinacsr.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\",\"name\":\"ChinaCSR.com\",\"url\":\"https:\/\/www.chinacsr.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\",\"contentUrl\":\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\",\"width\":800,\"height\":620,\"caption\":\"ChinaCSR.com\"},\"image\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/China_CSR\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba\",\"name\":\"CSR and Sustainability Editor\",\"sameAs\":[\"http:\/\/www.chinacsr.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","description":"Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/","og_locale":"en_US","og_type":"article","og_title":"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","og_description":"Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers","og_url":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/","og_site_name":"ChinaCSR.com","article_published_time":"2005-12-22T00:54:01+00:00","og_image":[{"url":"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif","type":"","width":"","height":""}],"author":"CSR and Sustainability Editor","twitter_card":"summary_large_image","twitter_creator":"@China_CSR","twitter_site":"@China_CSR","twitter_misc":{"Written by":"CSR and Sustainability Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#article","isPartOf":{"@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/"},"author":{"name":"CSR and Sustainability Editor","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba"},"headline":"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing","datePublished":"2005-12-22T00:54:01+00:00","dateModified":"2005-12-22T00:54:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/"},"wordCount":161,"commentCount":0,"publisher":{"@id":"https:\/\/www.chinacsr.com\/en\/#organization"},"image":{"@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage"},"thumbnailUrl":"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/","url":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/","name":"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","isPartOf":{"@id":"https:\/\/www.chinacsr.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage"},"image":{"@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage"},"thumbnailUrl":"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif","datePublished":"2005-12-22T00:54:01+00:00","dateModified":"2005-12-22T00:54:01+00:00","description":"Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers","breadcrumb":{"@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#primaryimage","url":"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif","contentUrl":"http:\/\/www.chinacsr.com\/images\/sinovac_logo_120x60.gif"},{"@type":"BreadcrumbList","@id":"https:\/\/www.chinacsr.com\/en\/2005\/12\/22\/60-sinovac-biotech-begins-h5n1-vaccine-clinical-trials-in-beijing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.chinacsr.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing"}]},{"@type":"WebSite","@id":"https:\/\/www.chinacsr.com\/en\/#website","url":"https:\/\/www.chinacsr.com\/en\/","name":"ChinaCSR.com","description":"Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","publisher":{"@id":"https:\/\/www.chinacsr.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.chinacsr.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.chinacsr.com\/en\/#organization","name":"ChinaCSR.com","url":"https:\/\/www.chinacsr.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","contentUrl":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","width":800,"height":620,"caption":"ChinaCSR.com"},"image":{"@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/China_CSR"]},{"@type":"Person","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba","name":"CSR and Sustainability Editor","sameAs":["http:\/\/www.chinacsr.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts\/60","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/comments?post=60"}],"version-history":[{"count":0,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts\/60\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/media?parent=60"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/categories?post=60"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/tags?post=60"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}